Urine Cell-Free DNA Integrity Analysis for Early Detection of Prostate Cancer Patients
2015-01-01 Salvi, S; Gurioli, G; Martignano, F; Foca, F; Gunelli, R; Cicchetti, G; De Giorgi, U; Zoli, W; Calistri, D; Casadio, V
Salvage treatment of relapsed or refractory germ-cell tumours
2013-01-01 De Giorgi, U; Amadori, D
High-dose chemotherapy in adult patients with germ cell tumors
2003-01-01 De Giorgi, U; Papiani, G; Severini, G; Fiorentini, G; Marangolo, M; Rosti, G.
Outcome of oligoprogressing metastatic renal cell carcinoma patients treated with locoregional therapy: a multicenter retrospective analysis
2017-01-01 Santini, D; Ratta, R; Pantano, F; De Lisi, D; Maruzzo, M; Galli, L; Biasco, E; Farnesi, A; Buti, S; Sternberg, Cn; Cerbone, L; Di Lorenzo, G; Spoto, S; Sterpi, M; De Giorgi, U; Berardi, R; Torniai, M; Camerini, A; Massari, F; Procopio, G; Tonini, G
Systemic immune-inflammation index predicts the clinical outcome in patients with metastatic renal cell cancer treated with sunitinib
2016-01-01 Lolli, C; Basso, U; Derosa, L; Scarpi, E; Sava, T; Santoni, M; Crabb, Sj; Massari, F; Aieta, M; Conteduca, V; Maruzzo, M; La Russa, F; Wheater, M; Berardi, R; Galli, L; De Giorgi, U
Long-term follow-up of patients with poor prognosis germ cell tumor treated with early high-dose chemotherapy with hematopoietic progenitor cell support: a single-center experience
2004-01-01 De Giorgi, U; Rosti, G; Papiani, G; Marangolo, M.
Tumorlets in familial history of bronchopulmonary carcinoid.
2011-01-01 De Giorgi, U; Fanini, F; Amadori, D; Cancellieri, A; Fiorentini, G; Poletti, V; Barzon, L; Masi, G.
Urothelial Cancer: Inflammatory Mediators and Implications for Immunotherapy
2016-01-01 Schepisi, G; Santoni, M; Massari, F; Gurioli, G; Salvi, S; Conteduca, V; Montironi, R; De Giorgi, U
Oxaliplatin plus leucovorin and 5-fluorouracil (FOLFOX-4) as a salvage chemotherapy in heavily-pretreated platinum-resistant ovarian cancer
2018-01-01 Conteduca, V.; Gurioli, G.; Rossi, L.; Scarpi, E.; Lolli, C.; Schepisi, G.; Farolfi, A.; De Lisi, D.; Galla, V.; Burgio, S. L.; Menna, C.; Amadori, A.; Losi, L.; Amadori, D.; Costi, M. P.; De Giorgi, U.
Potential use of imatinib mesylate in ocular melanoma and liposarcoma expressing immunohistochemical c-KIT (CD117)
2003-01-01 Fiorentini, G; Rossi, S; Lanzanova, G; Bernardeschi, P; Dentico, P; De Giorgi, U
Clinical outcomes of castration-resistant prostate cancer treatments administered as third or fourth line following failure of docetaxel and other second-line treatment: Results of an Italian multicentre study
2015-01-01 Caffo, O; De Giorgi, U; Fratino, L; Alesini, D; Zagonel, V; Facchini, G; Gasparro, D; Ortega, C; Tucci, M; Verderame, F; Campadelli, E; Lo Re, G; Procopio, G; Sabbatini, R; Donini, M; Morelli, F; Sartori, D; Zucali, P; Carrozza, F; D'Angelo, A; Vicario, G; Massari, F; Santini, D; Sava, T; Messina, C; Fornarini, G; La Torre, L; Ricotta, R; Aieta, M; Mucciarini, C; Zustovich, F; Macrini, S; Burgio, Sl; Santarossa, S; D'Aniello, C; Basso, U; Tarasconi, S; Cortesi, E; Buttigliero, C; Ruatta, F; Veccia, A; Conteduca, V; Maines, F; Galligioni, E.
Questioning the Value of Fluorodeoxyglucose Positron Emission Tomography for Residual Lesions After Chemotherapy for Metastatic Seminoma: Results of an International Global Germ Cell Cancer Group Registry.
2018-01-01 8., Cathomas R; Klingbiel, D; Bernard, B; Lorch, A; Garcia Del Muro, X; Morelli, F; De Giorgi, U; Fedyanin, M; Oing, C; Haugnes, Hs; Hentrich, M; Fankhauser, C; Gillessen, S; Beyer, J.
Value of pharmacokinetic studies for patients with gastrointestinal stromal tumors
2013-01-01 De Giorgi, U
Treatment-related fatigue with sorafenib, sunitinib and pazopanib in patients with advanced solid tumors: an up-to-date review and meta-analysis of clinical trials
2015-01-01 Santoni, M; Conti, A; Massari, F; Arnaldi, G; Iacovelli, R; Rizzo, M; De Giorgi, U; Trementino, L; Procopio, G; Tortora, G; Cascinu, S.
Urinary RNA-based biomarkers for prostate cancer detection
2017-01-01 Martignano, F; Rossi, L; Maugeri, A; Gallà, V; Conteduca, V; De Giorgi, U; Casadio, V; Schepisi, G
Prognostic significance of host immune status in patients with late relapsing renal cell carcinoma treated with targeted therapy
2015-01-01 Santoni, M; Buti, S; Conti, A; Porta, C; Procopio, G; Sternberg, Cn; Bracarda, S; Basso, U; De Giorgi, U; Rizzo, M; Derosa, L; Ortega, C; Massari, F; Milella, M; Bersanelli, M; Cerbone, L; Muzzonigro, G; Burattini, L; Montironi, R; Santini, D; Cascinu, S
High-dose chemotherapy for triple negative breast cancer
2007-01-01 De Giorgi, U; Rosti, G; Frassineti, L; Kopf, B; Giovannini, N; Zumaglini, F; Marangolo, M
18F-Fluorocholine PET/CT for early response assessment in patients with metastatic castration-resistant prostate cancer treated with enzalutamide
2015-01-01 DE GIORGI, Ugo; Caroli, Paola; Scarpi, Emanuela; Conteduca, Vincenza; Burgio, Salvatore Luca; Menna, Cecilia; Moretti, Andrea; Galassi, Riccardo; Rossi, Lorena; Amadori, Dino; Paganelli, Giovanni; Matteucci, Federica
Polichemotherapy in overseventy breast cancer patients
2002-01-01 Marangolo, M; De Giorgi, U
Prognostic value of 18F-choline PET/CT metabolic parameters in patients with metastatic castration-resistant prostate cancer treated with abiraterone or enzalutamide
2018-01-01 Caroli, P; De Giorgi, U; Scarpi, E; Fantini, L; Moretti, A; Galassi, R; Celli, M; Conteduca, V; Rossi, L; Bianchi, E; Paganelli, G; Matteucci, F
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Urine Cell-Free DNA Integrity Analysis for Early Detection of Prostate Cancer Patients | 1-gen-2015 | Salvi, S; Gurioli, G; Martignano, F; Foca, F; Gunelli, R; Cicchetti, G; De Giorgi, U; Zoli, W; Calistri, D; Casadio, V | |
| Salvage treatment of relapsed or refractory germ-cell tumours | 1-gen-2013 | De Giorgi, U; Amadori, D | |
| High-dose chemotherapy in adult patients with germ cell tumors | 1-gen-2003 | De Giorgi, U; Papiani, G; Severini, G; Fiorentini, G; Marangolo, M; Rosti, G. | |
| Outcome of oligoprogressing metastatic renal cell carcinoma patients treated with locoregional therapy: a multicenter retrospective analysis | 1-gen-2017 | Santini, D; Ratta, R; Pantano, F; De Lisi, D; Maruzzo, M; Galli, L; Biasco, E; Farnesi, A; Buti, S; Sternberg, Cn; Cerbone, L; Di Lorenzo, G; Spoto, S; Sterpi, M; De Giorgi, U; Berardi, R; Torniai, M; Camerini, A; Massari, F; Procopio, G; Tonini, G | |
| Systemic immune-inflammation index predicts the clinical outcome in patients with metastatic renal cell cancer treated with sunitinib | 1-gen-2016 | Lolli, C; Basso, U; Derosa, L; Scarpi, E; Sava, T; Santoni, M; Crabb, Sj; Massari, F; Aieta, M; Conteduca, V; Maruzzo, M; La Russa, F; Wheater, M; Berardi, R; Galli, L; De Giorgi, U | |
| Long-term follow-up of patients with poor prognosis germ cell tumor treated with early high-dose chemotherapy with hematopoietic progenitor cell support: a single-center experience | 1-gen-2004 | De Giorgi, U; Rosti, G; Papiani, G; Marangolo, M. | |
| Tumorlets in familial history of bronchopulmonary carcinoid. | 1-gen-2011 | De Giorgi, U; Fanini, F; Amadori, D; Cancellieri, A; Fiorentini, G; Poletti, V; Barzon, L; Masi, G. | |
| Urothelial Cancer: Inflammatory Mediators and Implications for Immunotherapy | 1-gen-2016 | Schepisi, G; Santoni, M; Massari, F; Gurioli, G; Salvi, S; Conteduca, V; Montironi, R; De Giorgi, U | |
| Oxaliplatin plus leucovorin and 5-fluorouracil (FOLFOX-4) as a salvage chemotherapy in heavily-pretreated platinum-resistant ovarian cancer | 1-gen-2018 | Conteduca, V.; Gurioli, G.; Rossi, L.; Scarpi, E.; Lolli, C.; Schepisi, G.; Farolfi, A.; De Lisi, D.; Galla, V.; Burgio, S. L.; Menna, C.; Amadori, A.; Losi, L.; Amadori, D.; Costi, M. P.; De Giorgi, U. | |
| Potential use of imatinib mesylate in ocular melanoma and liposarcoma expressing immunohistochemical c-KIT (CD117) | 1-gen-2003 | Fiorentini, G; Rossi, S; Lanzanova, G; Bernardeschi, P; Dentico, P; De Giorgi, U | |
| Clinical outcomes of castration-resistant prostate cancer treatments administered as third or fourth line following failure of docetaxel and other second-line treatment: Results of an Italian multicentre study | 1-gen-2015 | Caffo, O; De Giorgi, U; Fratino, L; Alesini, D; Zagonel, V; Facchini, G; Gasparro, D; Ortega, C; Tucci, M; Verderame, F; Campadelli, E; Lo Re, G; Procopio, G; Sabbatini, R; Donini, M; Morelli, F; Sartori, D; Zucali, P; Carrozza, F; D'Angelo, A; Vicario, G; Massari, F; Santini, D; Sava, T; Messina, C; Fornarini, G; La Torre, L; Ricotta, R; Aieta, M; Mucciarini, C; Zustovich, F; Macrini, S; Burgio, Sl; Santarossa, S; D'Aniello, C; Basso, U; Tarasconi, S; Cortesi, E; Buttigliero, C; Ruatta, F; Veccia, A; Conteduca, V; Maines, F; Galligioni, E. | |
| Questioning the Value of Fluorodeoxyglucose Positron Emission Tomography for Residual Lesions After Chemotherapy for Metastatic Seminoma: Results of an International Global Germ Cell Cancer Group Registry. | 1-gen-2018 | 8., Cathomas R; Klingbiel, D; Bernard, B; Lorch, A; Garcia Del Muro, X; Morelli, F; De Giorgi, U; Fedyanin, M; Oing, C; Haugnes, Hs; Hentrich, M; Fankhauser, C; Gillessen, S; Beyer, J. | |
| Value of pharmacokinetic studies for patients with gastrointestinal stromal tumors | 1-gen-2013 | De Giorgi, U | |
| Treatment-related fatigue with sorafenib, sunitinib and pazopanib in patients with advanced solid tumors: an up-to-date review and meta-analysis of clinical trials | 1-gen-2015 | Santoni, M; Conti, A; Massari, F; Arnaldi, G; Iacovelli, R; Rizzo, M; De Giorgi, U; Trementino, L; Procopio, G; Tortora, G; Cascinu, S. | |
| Urinary RNA-based biomarkers for prostate cancer detection | 1-gen-2017 | Martignano, F; Rossi, L; Maugeri, A; Gallà, V; Conteduca, V; De Giorgi, U; Casadio, V; Schepisi, G | |
| Prognostic significance of host immune status in patients with late relapsing renal cell carcinoma treated with targeted therapy | 1-gen-2015 | Santoni, M; Buti, S; Conti, A; Porta, C; Procopio, G; Sternberg, Cn; Bracarda, S; Basso, U; De Giorgi, U; Rizzo, M; Derosa, L; Ortega, C; Massari, F; Milella, M; Bersanelli, M; Cerbone, L; Muzzonigro, G; Burattini, L; Montironi, R; Santini, D; Cascinu, S | |
| High-dose chemotherapy for triple negative breast cancer | 1-gen-2007 | De Giorgi, U; Rosti, G; Frassineti, L; Kopf, B; Giovannini, N; Zumaglini, F; Marangolo, M | |
| 18F-Fluorocholine PET/CT for early response assessment in patients with metastatic castration-resistant prostate cancer treated with enzalutamide | 1-gen-2015 | DE GIORGI, Ugo; Caroli, Paola; Scarpi, Emanuela; Conteduca, Vincenza; Burgio, Salvatore Luca; Menna, Cecilia; Moretti, Andrea; Galassi, Riccardo; Rossi, Lorena; Amadori, Dino; Paganelli, Giovanni; Matteucci, Federica | |
| Polichemotherapy in overseventy breast cancer patients | 1-gen-2002 | Marangolo, M; De Giorgi, U | |
| Prognostic value of 18F-choline PET/CT metabolic parameters in patients with metastatic castration-resistant prostate cancer treated with abiraterone or enzalutamide | 1-gen-2018 | Caroli, P; De Giorgi, U; Scarpi, E; Fantini, L; Moretti, A; Galassi, R; Celli, M; Conteduca, V; Rossi, L; Bianchi, E; Paganelli, G; Matteucci, F |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile
Scopri
Tipologia
- 03 Articolo su Rivista38605
Data di pubblicazione
- In corso di stampa43
- 2020 - 202710433
- 2010 - 201913552
- 2000 - 20098692
- 1990 - 19993962
- 1980 - 19891442
- 1970 - 1979447
- 1961 - 196934
Editore
- Elsevier BV:PO Box 211, 1000 AE A...454
- American Institute of Physics:2 H...272
- Giuffre Editore Spa:via Busto Ars...128
- Elsevier Science Limited:Oxford F...99
- Congedo Editore Luogo pubbl. Gal...72
- IOP Publishing Limited:Dirac Hous...71
- Springer Verlag Germany:Tiergarte...71
- Kluwer Academic Publishers:Journa...54
- IEEE / Institute of Electrical an...47
- Societa Editrice il Mulino Spa:St...43
Rivista
- JOURNAL OF HIGH ENERGY PHYSICS481
- THE EUROPEAN PHYSICAL JOURNAL. C,...393
- PHYSICS LETTERS. SECTION B392
- PHYSICAL REVIEW LETTERS211
- APPLIED PHYSICS LETTERS186
- NUCLEAR INSTRUMENTS AND METHODS I...185
- THE ASTROPHYSICAL JOURNAL180
- PHYSICAL REVIEW D, PARTICLES, FIE...156
- PHYSICAL REVIEW D148
- ITINERARI DI RICERCA STORICA140
Keyword
- ATLAS1158
- LHC1151
- High Energy Physics1130
- Humans376
- Mediterranean Sea185
- Italy177
- Female144
- Animals143
- Male127
- Hadron-Hadron Scattering122
Lingua
- eng25985
- ita9002
- fre415
- spa191
- ger146
- por94
- lat51
- grc47
- rus43
- chi13
Accesso al fulltext
- no fulltext32279
- open4081
- restricted1185
- reserved1012
- partially open32
- mixed10
- embargoed6